Name

CHD-R

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for CHD-R

Name

Alternate Names

ENT 50852
ENT-50852
Hemel
Hexalen
hexamethyl- (8CI)
Hexamethylenamine
Hexamethylmelamine
Hexastat
Melamine
NC 195
NCI-C50259

Abbreviations

HMM
HTM
HXM

Category

Chemotherapy

Subcategory

Cytotoxic antineoplastic

NSC Number

013875
13875

Primary Site

Ovarian cancer

Histology

None

Remarks

Antineoplastic. FDA approved for ovarian cancer use.

Coding

This drug should be coded

Name

Alternate Names

Cis-Platin
Cis-Platinum II#
Cisplatino (Spanish)
Cisplatinum
Cisplatyl
Neoplatin
Peyrone's chloride
Platinex
Platinol
Platinol-AQ
Platinol-AQ VHA Plus
Platinum

Abbreviations

CACP
CDDP
Cis-DDP
CPD
CPDC
CPDD
CPPD
DDP

Category

Chemotherapy

Subcategory

Alkylating agent
Platinum analog

NSC Number

119875

Primary Site

Bladder
ovarian
testicular cancer

Histology

None

Remarks

An alkylating antineoplastic agent. FDA approved uses on bladder, ovarian and testicular cancer; miscellaneous agent.

Coding

This drug should be coded

Name

Alternate Names

Ancef
Apo-Cefaclor
Apo-Cephalex
Ceclor
Ceclor CD
Cedax
Cefaclor
Cefadroxil
Cefadyl
Cefamandole
Cefazolin
Cefdinir
Cefditoren
Cefepime
Cefixime
Cefizox
Cefobid
Cefonicid
Cefoperazone
Cefotan
Cefotaxime
Cefotetan
Cefoxitin
Cefpodoxime
Cefprozil
Ceftazidime
Ceftibuten
Ceftin
Ceftizoxime
Ceftriaxone
Cefuroxime
Cefzil
Cephalexin
Cephalothin
Cephapirin
Cephradine
Ceporacin
Ceptaz
Claforan
Duricef
Fortaz
Keflex
Keflin
Keftab
Kefurox
Kefzol
Mandol
Maxipime
Mefoxin
Monocid
Novo-Lexin
Nu-Cephalex
Omnicef
PMS-Cephalexin
Rocephin
Suprax
Tazicef
Tazidime
Vantin
Velosef
Zinacef

Abbreviations

None

Category

Ancillary Agent

Subcategory

Antibacterial

NSC Number

None

Primary Site

None

Histology

None

Remarks

None

Coding

This drug should NOT be coded

Name

Alternate Names

Asta B 518
B-518
Clafen Claphene
Cyclophosphamid
Cyclophosphan
Cyclophosphane
Cytophosphan
Cytoxan
Endoxan
Endoxana
Enduxan
Genoxal
Neosar
Procytox
Sendoxan
Tymtram
WR-138719

Abbreviations

CP
CPM
CTX
CTY
CYC
Cyclo
CYT
CYTOX
CYTX

Category

Chemotherapy

Subcategory

Alkylating agent

NSC Number

026271
26271

Primary Site

Breast
leukemia
lymphoma
multiple myeloma
neuroblastoma
ovarian cancer
retinoblastoma
soft tissue sarcoma
Wilm's tumor

Histology

None

Remarks

An effective antineoplastic agent and is used for a variety of cancers. FDA approved uses on breast cancer, ovarian carcinoma, leukemia, lymphomas, multiple myeloma, neuroblastma, retinoblastoma, soft tissue sarcoma, Wilm's tumor. Alkylating agent

Coding

This drug should be coded
Glossary